AKT1 and breast cancer: A recent study in BC cells, using a single cell approach with fluorescent receptor and Akt and ERK pathways activation reporters, demonstrated a highly heterogeneous response of cell subsets to CXCL12 (from strong to undetectable) and that changing tumor cell environmental inputs alters CXCR4 responsiveness [33].